Guangdong Transtek Medical Electronics Co Ltd (300562) — Working Capital to Net Assets Ratio

Latest as of September 2025: 56.9%

Guangdong Transtek Medical Electronics Co Ltd (300562) has a Working Capital to Net Assets ratio of 56.9% as of September 2025. Working capital of CN¥564.54 Million (current assets of CN¥975.11 Million minus current liabilities of CN¥410.57 Million) is measured against net assets of CN¥992.41 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See how leveraged is Guangdong Transtek Medical Electronics C's balance sheet to measure how much of total assets are equity-financed.

WC/NA Ratio

56.9%
Working Capital / Net Assets

Working Capital

CN¥564.54 Million
CNY

Current Assets

CN¥975.11 Million
CNY

Current Liabilities

CN¥410.57 Million
CNY

Guangdong Transtek Medical Electronics Co Ltd Working Capital to Net Assets (2011–2024)

This chart shows how Guangdong Transtek Medical Electronics Co Ltd's Working Capital to Net Assets ratio has evolved across 14 annual periods from 2011 to 2024. As of September 2025, the ratio stands at 56.9%, reflecting working capital of CN¥564.54 Million against net assets of CN¥992.41 Million CNY. Check tangible net worth ratio of Guangdong Transtek Medical Electronics C to evaluate the tangible quality of the company's equity base.

Annual Working Capital to Net Assets for Guangdong Transtek Medical Electronics Co Ltd (2011–2024)

The table below presents the year-by-year Working Capital to Net Assets ratio for Guangdong Transtek Medical Electronics Co Ltd from 2011 to 2024, covering 14 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Guangdong Transtek Medical Electronics C market capitalisation.

Year WC/NA Ratio Working Capital (CNY) Net Assets Current Assets Current Liabilities Change (pp)
2024 54.2% CN¥529.64 Million CN¥976.51 Million CN¥1.05 Billion CN¥516.91 Million ▲ +4.5 pp
2023 49.8% CN¥509.88 Million CN¥1.02 Billion CN¥999.40 Million CN¥489.52 Million ▲ +1.3 pp
2022 48.4% CN¥483.81 Million CN¥998.78 Million CN¥985.13 Million CN¥501.32 Million ▲ +2.7 pp
2021 45.8% CN¥479.58 Million CN¥1.05 Billion CN¥1.19 Billion CN¥711.35 Million ▲ +13.1 pp
2020 32.7% CN¥213.95 Million CN¥655.01 Million CN¥927.74 Million CN¥713.78 Million ▼ -7.2 pp
2019 39.9% CN¥226.43 Million CN¥568.05 Million CN¥636.98 Million CN¥410.55 Million ▼ -6.5 pp
2018 46.4% CN¥246.65 Million CN¥531.97 Million CN¥592.41 Million CN¥345.76 Million ▼ -0.4 pp
2017 46.7% CN¥240.39 Million CN¥514.28 Million CN¥480.87 Million CN¥240.48 Million ▼ -23.9 pp
2016 70.6% CN¥357.39 Million CN¥506.16 Million CN¥510.04 Million CN¥152.66 Million ▲ +17.5 pp
2015 53.2% CN¥119.40 Million CN¥224.63 Million CN¥236.50 Million CN¥117.09 Million ▼ -4.2 pp
2014 57.4% CN¥108.29 Million CN¥188.74 Million CN¥211.00 Million CN¥102.71 Million ▲ +10.4 pp
2013 47.0% CN¥57.47 Million CN¥122.26 Million CN¥153.98 Million CN¥96.51 Million ▼ -17.9 pp
2012 64.9% CN¥59.45 Million CN¥91.56 Million CN¥127.50 Million CN¥68.05 Million ▲ +16.4 pp
2011 48.6% CN¥30.55 Million CN¥62.90 Million CN¥83.91 Million CN¥53.36 Million
pp = percentage points